Inhibition of Schistosoma Mansoni Carbonic Anhydrase by the Antiparasitic Drug Clorsulon: X-ray Crystallographic and in Vitro Studies
Overview
Affiliations
Clorsulon is an anthelmintic drug that is clinically used against Fasciola hepatica. Due to the presence of two sulfonamide moieties in its core nucleus, which are well recognized as zinc-binding groups, it was proposed that it may be efficacious in the inhibition of parasite carbonic anhydrases (CAs). Proteomic analyses revealed the presence of CA in the tegument of Schistosoma mansoni, and recently the druggability of this target was explored by testing the inhibitory activities of several sulfonamide-based derivatives. According to the principles of drug repurposing, the aim was to demonstrate a putative new mechanism of action of clorsulon and thus widen its antiparasitic spectrum. For this purpose, the inhibitory activity and isoform selectivity of clorsulon was studied using human CA I and S. mansoni CA, revealing different modes of binding of clorsulon that explain its inhibitory potency against the two enzymes. The information obtained in this study could be crucial in the design of more active and selective derivatives.
Tetrazole Is a Novel Zinc Binder Chemotype for Carbonic Anhydrase Inhibition.
Giovannuzzi S, Angeli A, Begines P, Ferraroni M, Nocentini A, Supuran C ACS Med Chem Lett. 2025; 16(1):163-166.
PMID: 39811134 PMC: 11726385. DOI: 10.1021/acsmedchemlett.4c00562.
Vanda H, Athaillah F, Sari W, Frengki F, Nurliana N, Hambal M Open Vet J. 2024; 14(11):2754-2761.
PMID: 39737050 PMC: 11682782. DOI: 10.5455/OVJ.2024.v14.i11.4.
Anthelmintic potential of sulphonamides and seeds extract on experimentally infected mice.
Ashour D, Deyab F, Eliwa K, El-Kowrany S J Parasit Dis. 2023; 47(4):697-706.
PMID: 38009148 PMC: 10667198. DOI: 10.1007/s12639-023-01620-8.
Blanco-Paniagua E, Alvarez-Fernandez L, Rodriguez-Alonso A, Millan-Garcia A, Alvarez A, Merino G Antimicrob Agents Chemother. 2023; 67(5):e0009523.
PMID: 37078871 PMC: 10190675. DOI: 10.1128/aac.00095-23.
Haapanen S, Angeli A, Tolvanen M, Zolfaghari Emameh R, Supuran C, Parkkila S J Enzyme Inhib Med Chem. 2023; 38(1):2184299.
PMID: 36856011 PMC: 9980027. DOI: 10.1080/14756366.2023.2184299.